Seiichi Yuza
Keine laufenden Positionen mehr
Karriereverlauf von Seiichi Yuza
Ehemalige bekannte Positionen von Seiichi Yuza
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Allgene, Inc. | Direktor/Vorstandsmitglied | 01.05.2015 | - |
Titan, Inc. (Japan)
 Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Direktor/Vorstandsmitglied | 01.12.2018 | - |
| TELLA, INC. | Direktor/Vorstandsmitglied | 01.12.2008 | - |
| Geschäftsführer | 01.12.2008 | 13.09.2018 | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.12.2008 | 01.07.2013 | |
| Corporate Officer/Principal | 01.07.2013 | 01.03.2017 | |
| Präsident | 13.09.2018 | 01.03.2019 |
Ausbildung von Seiichi Yuza
| University of Tokyo | Doctorate Degree |
Statistik
International
| Japan | 5 |
Operativ
| Director/Board Member | 3 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sektoral
| Consumer Services | 2 |
| Technology Services | 2 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Titan, Inc. (Japan)
Titan, Inc. (Japan) Data Processing ServicesTechnology Services Titan, Inc. provides imaging solutions and clinical trial support services. The company was founded on May 2, 2013 and is headquartered in Tokyo, Japan. | Technology Services |
| Allgene, Inc. | |
tella, Inc.
 tella, Inc. BiotechnologyHealth Technology tella, Inc. engages in research and development of dendritic cell (DC) vaccine therapy. It operates through the following segments: Cell Medicine, Medical Support, and Pharmaceuticals. The Cell Medicine segment provides cancer treatment technology and know-hows centered on dendritic cell vaccine therapy. The Medical Support segment manages contact research organization (CRO) business and offers genetic testing services. The Pharmaceuticals segment deals with the development of dendritic cell vaccine as a cancer treatment. The company was founded by Yuichiro Yazaki on June 24, 2004 and is headquartered in Tokyo, Japan. | Health Technology |
- Börse
- Insiders
- Seiichi Yuza
- Erfahrung
